These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 9674714)

  • 1. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.
    Fowler FJ; Bin L; Collins MM; Roberts RG; Oesterling JE; Wasson JH; Barry MJ
    Am J Med; 1998 Jun; 104(6):526-32. PubMed ID: 9674714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urologists' personal feelings on PSA screening and prostate cancer treatment.
    Wenzler DL; Rosenberg BH
    J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
    McNaughton Collins M; Stafford RS; Barry MJ
    J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
    South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Thompson RH; Han LC; Shah ND; Smaldone MC; Gross CP; Frank I; Weight CJ; Beebe TJ; Tilburt JC
    BJU Int; 2014 May; 113(5b):E106-11. PubMed ID: 24053213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
    Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.
    Wilt TJ
    Semin Urol Oncol; 2002 Feb; 20(1):10-7. PubMed ID: 11828353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What should men know about prostate-specific antigen screening before giving informed consent?
    Chan EC; Sulmasy DP
    Am J Med; 1998 Oct; 105(4):266-74. PubMed ID: 9809686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States.
    Sylvester J; Grimm P; Blasco J; Meier R; Spiegel J; Heaney C; Cavanagh W
    Urology; 2001 Aug; 58(2 Suppl 1):65-70. PubMed ID: 11502452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
    Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
    BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Swiss urologists and Swiss internists screen themselves and their relatives for prostate cancer? A questionnaire study.
    Scherer TP; Saba K; Wettstein MS; Lucca I; Mortezavi A; Waisbrod S; Aujesky D; Capaul R; Strebel RT
    Swiss Med Wkly; 2023 Sep; 153():40115. PubMed ID: 37774392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey.
    Chan EC; Barry MJ; Vernon SW; Ahn C
    J Gen Intern Med; 2006 Mar; 21(3):257-9. PubMed ID: 16637825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advantages and risks of the use of prostate-specific antigen (PSA) in the health-care area No. 4 of Gijon (Asturias)].
    Cepeda Piorno J; Rivas del Fresno M; Fuente Martín E; González García E; Muruamendiaraz Fernández V; Fernández Rodríguez E
    Arch Esp Urol; 2005 Jun; 58(5):403-11. PubMed ID: 16078781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening. What family physicians believe is best.
    Hicks RJ; Hamm RM; Bemben DA
    Arch Fam Med; 1995 Apr; 4(4):317-22. PubMed ID: 7711917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices.
    Perez TY; Danzig MR; Ghandour RA; Badani KK; Benson MC; McKiernan JM
    Urology; 2015 Jan; 85(1):85-9. PubMed ID: 25440819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.